Skip to main content
. 2014 Aug 5;2(6):855–860. doi: 10.3892/br.2014.330

Figure 2.

Figure 2

Pharmacokinetic profiles of perindopril in combination with Chungsinoryungsan within 5 min. The plasma samples used in Fig. 1 were subjected to analyses of pharmacokinetic parameters: (A) Peak concentration (Cmax), (B) time to reach the Cmax (Tmax), (C) terminal half-life (t1/2), (D) area under the perindopril concentration-time curve (AUC0-t), (E) AUC zero to infinity (AUC0-inf) and (F) mean residence time to infinity (MRTinf). Each graph represents average values ± SEM in the combination (Combi, white bars) and control (con, black bars). *P<0.01.